Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 3 studies | 21% ± 6% |
Insufficient scRNA-seq data for expression of CEP19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 470.94 | 2639 / 2642 | 100% | 14.68 | 703 / 705 |
thymus | 98% | 213.44 | 643 / 653 | 96% | 6.15 | 582 / 605 |
uterus | 96% | 162.76 | 163 / 170 | 93% | 9.97 | 429 / 459 |
breast | 93% | 125.12 | 427 / 459 | 95% | 6.84 | 1064 / 1118 |
kidney | 98% | 189.35 | 87 / 89 | 88% | 5.26 | 794 / 901 |
ovary | 94% | 152.49 | 170 / 180 | 90% | 5.56 | 385 / 430 |
adrenal gland | 94% | 188.46 | 243 / 258 | 89% | 5.86 | 204 / 230 |
prostate | 98% | 175.79 | 239 / 245 | 83% | 3.37 | 418 / 502 |
lung | 92% | 180.23 | 531 / 578 | 88% | 8.95 | 1017 / 1155 |
bladder | 95% | 149.90 | 20 / 21 | 70% | 3.49 | 351 / 504 |
skin | 67% | 118.48 | 1207 / 1809 | 96% | 8.33 | 452 / 472 |
esophagus | 90% | 136.49 | 1301 / 1445 | 72% | 5.73 | 132 / 183 |
intestine | 85% | 133.97 | 822 / 966 | 65% | 2.31 | 340 / 527 |
stomach | 54% | 70.38 | 194 / 359 | 62% | 2.14 | 176 / 286 |
pancreas | 27% | 21.14 | 87 / 328 | 81% | 3.83 | 144 / 178 |
spleen | 100% | 302.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 16.39 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 10.23 | 28 / 29 |
peripheral blood | 94% | 754.10 | 871 / 929 | 0% | 0 | 0 / 0 |
adipose | 94% | 142.91 | 1126 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 76% | 88.39 | 1009 / 1335 | 0% | 0 | 0 / 0 |
heart | 73% | 86.36 | 632 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 2.14 | 50 / 80 |
liver | 20% | 15.97 | 46 / 226 | 28% | 1.07 | 113 / 406 |
muscle | 25% | 22.72 | 202 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060271 | Biological process | cilium assembly |
GO_0034454 | Biological process | microtubule anchoring at centrosome |
GO_0097712 | Biological process | vesicle targeting, trans-Golgi to periciliary membrane compartment |
GO_0005814 | Cellular component | centriole |
GO_0005813 | Cellular component | centrosome |
GO_0005929 | Cellular component | cilium |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000922 | Cellular component | spindle pole |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | CEP19 |
Protein name | Centrosomal protein of 19 kDa Centrosomal protein of 19 kDa (Cep19) |
Synonyms | C3orf34 HSD5 |
Description | FUNCTION: Required for ciliation . Recruits the RABL2B GTPase to the ciliary base to initiate ciliation. After specifically capturing the activated GTP-bound RABL2B, the CEP19-RABL2B complex binds intraflagellar transport (IFT) complex B from the large pool pre-docked at the base of the cilium and thus triggers its entry into the cilia . Involved in the early steps in cilia formation by recruiting the ciliary vesicles (CVs) to the distal end of the mother centriole where they fuse to initiate cilium assembly. Involved in microtubule (MT) anchoring to the centrosomes . . |
Accessions | ENST00000399942.4 ENST00000409690.5 Q96LK0 A8MX07 |